Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
losartan type-1 angiotensin ii receptor small molecule NA drugbank , DGIDB Hypertensive disease[MeSHID:D006973]
Left Ventricular Hypertrophy[MeSHID:D017379]
Serum[MeSHID:D044967]
Diabetic Nephropathy[MeSHID:D003928]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Proteinuria[MeSHID:D011507]
Cerebrovascular accident[MeSHID:D020521]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 2.31 approved antagonist
losartan angiotensin ii receptor type-1 NA Successful target TTD , DGIDB Hypertensive disease[MeSHID:D006973]
Left Ventricular Hypertrophy[MeSHID:D017379]
Serum[MeSHID:D044967]
Diabetic Nephropathy[MeSHID:D003928]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Proteinuria[MeSHID:D011507]
Cerebrovascular accident[MeSHID:D020521]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 2.31 approved unknown
losartan type-1 angiotensin ii receptor small molecule NA drugbank , DGIDB Hypertensive disease[MeSHID:D006973]
Left Ventricular Hypertrophy[MeSHID:D017379]
Serum[MeSHID:D044967]
Diabetic Nephropathy[MeSHID:D003928]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Proteinuria[MeSHID:D011507]
Cerebrovascular accident[MeSHID:D020521]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 2.31 approved antagonist
losartan angiotensin ii receptor type-1 NA Successful target TTD , DGIDB Hypertensive disease[MeSHID:D006973]
Left Ventricular Hypertrophy[MeSHID:D017379]
Serum[MeSHID:D044967]
Diabetic Nephropathy[MeSHID:D003928]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Proteinuria[MeSHID:D011507]
Cerebrovascular accident[MeSHID:D020521]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 2.31 approved antagonist
losartan angiotensin ii receptor type-1 NA Successful target TTD , DGIDB Hypertensive disease[MeSHID:D006973]
Left Ventricular Hypertrophy[MeSHID:D017379]
Serum[MeSHID:D044967]
Diabetic Nephropathy[MeSHID:D003928]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Proteinuria[MeSHID:D011507]
Cerebrovascular accident[MeSHID:D020521]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 2.31 approved unknown
losartan angiotensin ii receptor type-1 NA Successful target TTD , DGIDB Hypertensive disease[MeSHID:D006973]
Left Ventricular Hypertrophy[MeSHID:D017379]
Serum[MeSHID:D044967]
Diabetic Nephropathy[MeSHID:D003928]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Proteinuria[MeSHID:D011507]
Cerebrovascular accident[MeSHID:D020521]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Disease[MeSHID:D004194]		 2.31 approved antagonist
click here to return to the previous page